Respiratory infections and psoriasis: Relationship and clinical aspects. Case report

Cover Page

Cite item

Full Text

Abstract

Respiratory infections are among the most common infectious diseases. The influenza epidemic and the coronavirus pandemic have demonstrated how quickly respiratory diseases can spread, causing serious social and economic consequences. Respiratory infections have multiple effects on various parts of the immune system; they can aggravate chronic diseases and contribute to the exacerbation or onset of autoimmune diseases, including skin conditions. Any infectious process activates the immune system, triggering an inflammatory response. In autoimmune diseases, such as psoriasis, the immune system is already overactive, and additional stimulation can lead to increased inflammation in the skin and exacerbation of symptoms. Induction of psoriasis guttata was previously described only by a tonsil infection caused by Streptococcus pyogenes. Currently, evidence has been accumulated on the effect of various viral infections, including SARS-CoV-2, on the course of psoriasis. Cases of the onset of psoriasis guttata and common plaque psoriasis, which is resistant to topical therapy after coronavirus infection, have been reported. A clinically significant problem is the exacerbation of psoriasis and its transformation into more severe and resistant forms. Given the presence of comorbidities in most patients, it is necessary to develop an individual approach to achieve the key goals of a modern therapeutic approach – its maximum effectiveness and safety. The article presents a literature review and a clinical case demonstrating the torpid course of psoriasis with onset after a coronavirus infection.

About the authors

Ksenia V. Katkova

Center for Theoretical Problems of Physicochemical Pharmacology; Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Email: marykor@bk.ru
ORCID iD: 0000-0002-7794-489X

Res. Assist.

Russian Federation, Moscow; Moscow

Elena V. Denisova

Center for Theoretical Problems of Physicochemical Pharmacology; Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Email: marykor@bk.ru
ORCID iD: 0000-0002-4887-284X

Cand. Sci. (Med.)

Russian Federation, Moscow; Moscow

Irina M. Korsunskaya

Center for Theoretical Problems of Physicochemical Pharmacology; Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology

Author for correspondence.
Email: marykor@bk.ru
ORCID iD: 0000-0002-6583-0318

D. Sci. (Med.), Prof.

Russian Federation, Moscow; Moscow

References

  1. Zhu H, Lou F, Yin Q, et al. RIG-I antiviral signaling drives interleukin-23 production and psoriasis-like skin disease. EMBO Mol Med. 2017;9(5):589-604. doi: 10.15252/emmm.201607027
  2. Rychik KM, Yousefzadeh N, Glass AT. Guttate psoriasis following presumed coxsackievirus A. Cutis. 2019;104(4):248-9.
  3. Lionel Fry, Barbara S. Baker, Triggering psoriasis: the role of infections and medications. Clin Dermatol. 2007;25(6):606-15.
  4. Sbidian E, Madrange M, Viguier M, et al. Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds. Br J Dermatol. 2019;181(6):1304-6. doi: 10.1111/bjd.18203
  5. Rouai M, Rabhi F, Mansouri N, et al. New-onset guttate psoriasis secondary to COVID-19. Clin Case Rep. 2021;9(7):e04542. doi: 10.1002/ccr3.4542
  6. Demiri J, Abdo M, Tsianakas A. Erythroderme Psoriasis nach COVID-19-Erkrankung [Erythrodermic psoriasis after COVID-19]. Hautarzt. 2022;73(2):156-9. doi: 10.1007/s00105-021-04931-0
  7. Ali Khan Q, Khan T, Anthony MR, et al. An Erythrodermic Psoriasis Flare-Up With Staphylococcus Bacteremia Secondary to COVID-19 Infection: A Case Report. Cureus. 2023;15(3):e36418. doi: 10.7759/cureus.36418
  8. Shahidi Dadras M, Diab R, Ahadi M, Abdollahimajd F. Generalized pustular psoriasis following COVID-19. Dermatol Ther. 2021;34(1):e14595. doi: 10.1111/dth.14595
  9. Miladi R, Janbakhsh A, Babazadeh A, et al. Pustular psoriasis flare-up in a patient with COVID-19. J Cosmet Dermatol. 2021;20(11):3364-8. doi: 10.1111/jocd.14508
  10. Narang T, Sharma A, Bhandari A, et al. SARS-CoV-19 and Generalised Pustular Psoriasis: A Lethal Combination. Indian J Dermatol. 2023;68(6):726. doi: 10.4103/ijd.ijd_914_22
  11. Murdock BN, Lowe JB, Yoo MJ. Post-COVID-19 rash: An atypical manifestation of guttate psoriasis. Am J Emerg Med. 2024;76:271.e1-3. doi: 10.1016/j.ajem.2023.12.008
  12. Каткова К.В., Плиева К.Т., Денисова Е.В., и др. Влияние коронавирусной инфекции на течение псориаза. Медицинский совет. 2021;12:332-8 [Katkova KV, Plieva KT, Denisova EV, Zhukova OV, Volnukhin AV, Korsunskaya IM. Influence of coronavirus infection on the course of psoriasis. Medical Council. 2021;(12):332-8 (in Russian)]. doi: 10.21518/2079- 701X-2021-12-332-338
  13. Ozaras R, Berk A, Ucar DH, et al. Covid-19 and exacerbation of psoriasis. Dermatol Ther. 2020;33(4):e13632. doi: 10.1111/dth.13632
  14. Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med (Lausanne). 2023;10:1011936. doi: 10.3389/fmed.2023.1011936

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Guttate psoriasis after COVID-19.

Download (250KB)

Copyright (c) 2025 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).